Very rare diseases in oncology
| Authors | |
|---|---|
| Year of publication | 2014 |
| Type | Article in Periodical |
| Magazine / Source | Medical oncology |
| MU Faculty or unit | |
| Citation | |
| Doi | http://dx.doi.org/10.1007/s12032-014-0947-y |
| Field | Oncology and hematology |
| Keywords | oncology diseases |
| Description | Chen et al. [1] presented an important study on potential molecular prognostic predictors of recurrence in sacral chordoma. I wish to draw the readers’ attention to epidemiological and related socioeconomic and ethical issues of such a rare diagnosis. Various definitions for sporadic diseases have been proposed based on different cutoff incidence or prevalence rates. Some of these definitions delineate a substantial portion of the overall population disease burden. The apparent complexity of the group of rare diseases implies further explorations including the most uncommon entities. |
| Related projects: |